发布时间：2008.5

摘要

Countries covered: Global

Datamonitor's Global Pharmaceuticals, Biotechnology & Life Sciences industry profile is an essential resource for top-level data and analysis covering the global pharmaceuticals, biotechnology & life sciences industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

• Contains an executive summary and data on value, volume and/or segmentation
• Provides textual analysis of the industry’s recent performance and future prospects
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Includes a five-year forecast of the industry
• The leading companies are profiled with supporting key financial metrics
• Supported by the key macroeconomic and demographic data affecting the market

Highlights

• Detailed information is included on market size, measured by value and/or volume
• Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape
• Market shares are covered by manufacturer or brand

Why you should buy this report

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Market Definition

The global pharmaceuticals, biotechnology, and life sciences industry group is composed of the pharmaceuticals market, the biotechnology market, and the life sciences tools and services market.

The pharmaceuticals market consists of both ethical and over the-counter (OTC) drugs, but does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). The market segmentation section of the report does not include OTC drugs, as this part of the report is intended to provide an illustration of the ethical drug therapeutic areas.

The biotechnology market profile reviews companies primarily involved in the development, manufacturing or marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this market from product sales, licensing fees, royalties and research funding.

The life sciences tools & services market is comprised of companies enabling the drug discovery, development and production continuum by providing analytical tools, instruments, consumables & supplies, clinical trial services and contract research services. However, the market value in this profile only includes revenues from clinical trial services and contract research services from firms primarily servicing the pharmaceutical and biotechnology industries.

Any currency conversions have been made at 2007 annual average exchange rates.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.

目录及图表

EXECUTIVE SUMMARY

CHAPTER 1 Market Overview

1.1 Market Definition

1.2 Research Highlights

1.3 Market Analysis

CHAPTER 2 Market Value

CHAPTER 3 Market Segmentation I

CHAPTER 4 Market Segmentation II

CHAPTER 5 Market Share

CHAPTER 6 Five Forces Analysis

6.1 Summary

6.2 Buyer Power

6.3 Supplier Power

6.4 New Entrants

6.5 Substitutes

6.6 Rivalry

CHAPTER 7 Leading Companies

7.1 Pfizer Inc

7.2 GlaxoSmithKline Plc

7.3 Sanofi-Aventis

CHAPTER 8 Market Forecasts

8.1 Market Value Forecast

CHAPTER 9 Appendix

9.1 Methodology

9.2 Industry Associations

LIST OF TABLES

Table 1: Global Pharmaceuticals, Biotechnology & Life Sciences Industry Group Value: $ billion, 2003-2007

Table 2: Global Pharmaceuticals, Biotechnology & Life Sciences Industry Group Segmentation I: % Share, by Value, 2007

Table 3: Global Pharmaceuticals, Biotechnology & Life Sciences Industry Group Segmentation II: % Share, by Value, 2007

Table 4: Global Pharmaceuticals, Biotechnology & Life Sciences Industry Group Share: % Share, by Value, 2007

Table 5: Key Facts: Pfizer Inc

Table 6: Key Financials: Pfizer Inc

Table 7: Key Facts: GlaxoSmithKline Plc

Table 8: Key Financials: GlaxoSmithKline Plc

Table 9: Key Facts: Sanofi-Aventis

Table 10: Key Financials: Sanofi-Aventis

Table 11: Global Pharmaceuticals, Biotechnology & Life Sciences Industry Group Value Forecast: $ billion, 2007-2012